Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells. - Elgehama A; Sun L; Yu B; Guo W; Xu Q (Investigational new drugs, 2021)